Class II · Moderate risk Ongoing
Amphotericin B Liposome for Injection
Reason Out of specification for assay
Liposomal Amphotericin B 130 mg in dextrose bags
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Lack of sterility assurance.
What was recalled
Liposomal Amphotericin B 130 mg in dextrose bags
- Recalling firm
- Walgreens Infusion Services
- Origin
- TX, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-0340-2015
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Amphotericin recalls
See all
Class II · Moderate risk Terminated
Amphotericin B Liposome for Injection
Reason Subpotent drug
Class II · Moderate risk Terminated
Abelcet
Reason Lack of assurance of sterility: Medial fill with presence of Cupriavidus pauculus.
Class II · Moderate risk Terminated
CSF-HC Otic Insufflation Capsule
Reason CGMP Deviations
Class II · Moderate risk Terminated
CSF Otic Insufflation Capsule
Reason CGMP Deviations
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.